Recombinant MS4A1 (Obinutuzumab Biosimilar) anticorps

N° du produit ABIN7795118

Cet anticorps Souris Monoclonal détecte spécifiquement MS4A1 (Obinutuzumab Biosimilar) dans FACS et in vivo. Il présente une réactivité envers Humain.

Aperçu rapide pour Recombinant MS4A1 (Obinutuzumab Biosimilar) anticorps (ABIN7795118)

Antigène: MS4A1 (Obinutuzumab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp MS4A1 (Obinutuzumab Biosimilar) est non-conjugé

Application: Flow Cytometry (FACS), In vivo Studies (in vivo)

Classe de qualité: Research Grade

Détail du produit anti-MS4A1 (Obinutuzumab Biosimilar) anticorps

Expression System: Mammalian cells

Fonction: Obinutuzumab Biosimilar, CD20 Monoclonal Antibody

Attributs du produit: Obinutuzumab Biosimilar uses the same protein sequences as the therapeutic antibody obinutuzumab. Obinutuzumab is an antineoplastic CD20 antibody used to treat untreated chronic lymphocytic leukemia in combination with chlorambucil. In contrast to rituximab, which is a classic type I CD20 antibody, obinutuzumab binds to type II CD20 antibodies. This allows obinutuzumab to have a much higher induction of antibody-dependant cytotoxicity and a higher direct cytotoxic effect than the classic CD20 antibodies.

Purification: Protein A or G affinity column

Pureté: >95 % by reducing SDS-PAGE

niveau d'endotoxine: < 1 EU per 1 mg of the protein by the LAL method

Immunogène: Human CD20

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: > 3 mg/mL

Stock: 4 °C,-20 °C

Stockage commentaire: Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.

Détails sur MS4A1 (Obinutuzumab Biosimilar)

Antigène: MS4A1 (Obinutuzumab Biosimilar)

Autre désignation: Obinutuzumab Biosimilar

Classe de substances: Biosimilar